Fixing of record date as July 10, 2026 for the purpose of payment of final dividend for FY 2025-26
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty 100 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. Reddy's Board has recommended a final dividend of INR 8 per equity share (face value Rs. 1) for FY 2025-26, subject to shareholder approval at the 42nd AGM scheduled for July 23, 2026. The record date for determining eligible shareholders has been fixed as July 10, 2026. The company also reported FY26 consolidated revenues of Rs. 335.9 billion, up 3.2% YoY, though Q4FY26 saw a significant decline due to lower Lenalidomide sales and a one-time Shelf Stock Adjustment of Rs. 4.53 billion. Full year profit after tax attributable to equity holders was Rs. 42.9 billion, down 24% YoY.
The dividend declaration signals continued shareholder returns despite a challenging year with profit decline. Investors who own shares by July 10, 2026 will receive the Rs. 8 per share dividend upon shareholder approval.